A. DeLuca, M. Frick, E. Lessem, J. Kanouse, D. Wegener and L. Ruiz Mingote
By
A. DeLuca, M. Frick, E. Lessem, J. Kanouse, D. Wegener and L. Ruiz Mingote
Published: Jan. 11, 2015, 9:50 p.m.·
Tags:
Access,
Advocacy
The article details the advocacy campaign that led Sanofi to decrease the price of TB drug rifapentine by 57% in the United States.
Read More →
Page 1 of 1 · Total posts: 1
1